Medimix Evidera

PPD expands patient access to clinical trials via collaboration with cancer center

New collaboration expands opportunities for cancer patients to be treated in the community setting.

Outsourcing-Pharma  (July 2019)

PPD group launches major dementia study, to include 30,000 people

Dawie Wessels discusses the five-year study to explore ways to prevent and treat dementia.

WRAL TechWire  (July 2019)

Five-year study to examine how healthy brains age: ‘Research is urgently needed,’ says AES

PPD business unit Accelerated Enrollment Solutions initiates the Synexus HealthyMinds Registry, which aims to register 30,000 adults for the study.

Outsourcing-Pharma  (July 2019)

ADC characterization

Christopher Bianchetti, Henry Parker, Kit Hanson and Stephen Gacheru discuss the potential of antibody-drug conjugates for the biopharmaceutical industry.

European Biopharmaceutical Review  (July 2019)

PPD unit Evidera buys up real-world evidence company Medimix

The addition of Medimix will enhance Evidera’s ability to leverage data to provide real-world evidence and insights for clients.

FierceBiotech  (June 2019)

Risk-based quality management: The importance of risk communication

Brian Barnes and Volker Hack discuss the ongoing efforts to encourage the implementation of improved and more efficient approaches to clinical trials.

Applied Clinical Trials  (June 2019)

GLPs: Better data access needed to improve compliance

Stuart Jones shares his thoughts on good laboratory practices best practices.

BioPharm International  (June 2019)

De-risking master protocol implementation

Brian Barnes and Rachael Song provide an overview and discuss the benefits of master protocol studies.

Applied Clinical Trials  (June 2019)

Good laboratory practices: Getting on the same page

Stuart Jones discusses the importance of training and other factors that can significantly impact quality.

Pharmaceutical Technology  (June 2019)

ICH E6 R2 – Best practices for implementing a more formal risk management process

Volker Hack and Brian Barnes discuss how to undertake a well-balanced approach that applies critical thinking and implements lessons learned.

Clinical Leader  (May 2019)

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.